Skip to main content
. Author manuscript; available in PMC: 2023 Apr 20.
Published in final edited form as: N Engl J Med. 2022 Nov 30;387(24):2294–2295. doi: 10.1056/NEJMc2210015

Table 1.

Patients’ baseline characteristics and outcomes

Demographic characteristics
Male : female 4 : 10
Age (years): median (range) 23 (4 – 38)
Comorbidities
Malaria: n/N (%) patients tested 11/13 (85%)
HIV: n/N (%) patients tested 1/3 (7%)
General characteristics
Time (days) from symptom onset to treatment start: median (range) 21 (5–45)
Signs and symptoms: n/N (%) patients
Fever (temperature >38·0 °C) 9/14 (64%)
Patients with lesions: 14/14 (100%)
Patients with new lesions 10/14 (71%)
Number of patients with >100 lesions 11/14 (79%)
Outcome: n/N (%) patients
Completed full course of treatment 14/14 (100%) 
PCR positive at day 4 7/14 (50%)
PCR positive at day 8 1/10 (10%)
PCR positive at day 14 1/8 (12%)
PCR positive at day 21 1/2 (50%)
PCR positive at final visit 1/13 (8%)
Time (days) to no new lesions: median (range) 5 (0–28)
Recovered without sequelae at D28 4/13 (31%)
Recovered with sequelae at D28 9/13 (69%)
Patients with at least one serious adverse event 2/14 (14%)